MedPath

SUFENTA INJ 50MCG/ML

SUFENTA INJ 50MCG/ML

Discontinued
DIN Number

00619744

Drug Class

Human

Market Date

Dec 31, 1985

Company
HC

janssen pharmaceutica, division of janssen-ortho inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00619744
AIG Number0144821001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N01AH03 SUFENTANIL
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

SUFENTANIL (SUFENTANIL CITRATE)Active
Strength: 50 MCG / ML
Monograph: SUFENTANIL (SUFENTANIL CITRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.